Breath Therapeutics

People living with rare lung disorders are at the center of everything we do. Founded in 2016, Breath Therapeutics is a private clinical-stage biopharmaceutical company specializing in advanced inhaled therapies for severe respiratory diseases with high unmet medical need. By combining novel formulations of existing drugs with cutting-edge inhalation technology to rapidly deliver high concentrations of drugs to the site of action in the lung, Breath Therapeutics is unleashing the true potential of inhaled drug delivery. This approach increases effective dosing in the lung while minimizing systemic exposure which could lead to new treatment solutions with enhanced efficacy and safety....

Rare lung disease;drug development;rare disease;inhalation therapies;bronchiolitis obliterans syndrome;bos;lung disease;lungs;therapeutics;rare respiratory diseases;respiratory diseases;biotech;biotechnology

Breath therapeutics's HQ phone number is +1 858-245-3983

Breath therapeutics's revenue is 11m - 100m

Breath therapeutics has 11 - 50 employees.